Genmab — August 2014
-
-
Filippa...køberne kunne få volumen da de købte kursen op. Da kursen stagnerede faldt volumen.....super godt tegn. Køberne vil ikke handle Genmab voldsomt op hver dag med mindre de ved der er nyheder lige om hjørnet. Det tilbagefald vi ser nu er helt efter bogen, idet det giver et bedre udgangspunkt for videre køb i morgen.
-
Fantastisk news... Nu stormer dara frem sammen med revlimid og velcade i både relapsed og frontline
-
Genmab A/S (GMXAY) -Other OTC Follow
20.86 Up 0.47(2.29%) 11:48AM EDT
Prev Close: 20.39
Open: 20.86
Bid: N/A
Ask: N/A
1y Target Est: N/A
Beta: N/A
Next Earnings Date: N/A
Day's Range: 20.86 - 20.86
52wk Range: 14.77 - 24.00
Volume: 65,644
Avg Vol (3m): 11,281
Market Cap: 2.36B
P/E (ttm): 87.82
EPS (ttm): 0.24
Div & Yield: N/A (N/A
Jeg så gerne kurs 1000 indenfor nogle år, men tror at hvis feks. J&J ser super potientiale i gen, at de køber det hele inden kursen for alvor stiger.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind